Filing Details
- Accession Number:
- 0001209191-22-035983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-10 17:03:03
- Reporting Period:
- 2022-05-02
- Accepted Time:
- 2022-06-10 17:03:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-02 | 101 | $2.45 | 185,311 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-03 | 101 | $2.42 | 185,412 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-04 | 101 | $2.37 | 185,513 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-05 | 101 | $2.35 | 185,614 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-06 | 101 | $2.36 | 185,715 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-09 | 114 | $2.63 | 185,829 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-10 | 114 | $2.55 | 185,943 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-11 | 114 | $2.37 | 186,057 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-12 | 114 | $2.23 | 186,171 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-13 | 114 | $2.32 | 186,285 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-16 | 114 | $2.31 | 186,399 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-17 | 114 | $2.35 | 186,513 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-18 | 114 | $2.31 | 186,627 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-19 | 114 | $2.29 | 186,741 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-20 | 114 | $2.23 | 186,855 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-23 | 127 | $2.17 | 186,982 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-24 | 127 | $2.17 | 187,109 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-25 | 127 | $2.15 | 187,236 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-26 | 127 | $2.12 | 187,363 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-27 | 127 | $2.13 | 187,490 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-29 | 127 | $2.13 | 187,617 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Billionaire Hedge Funds
